5.31 USD
+0.04 (+0.76%)
ChartMill assigns a Buy % Consensus number of 76% to BOLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.29. This target is 413.84% above the current price.
BOLT was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BOLT.
In the previous month the buy percentage consensus was at a similar level.
BOLT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-15 | Lake Street | Maintains | Buy -> Buy |
| 2025-05-20 | Lake Street | Initiate | Buy |
| 2025-05-13 | Stifel | Maintains | Hold -> Hold |
| 2025-03-25 | Stifel | Maintains | Hold -> Hold |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-05-15 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-05-15 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-05-15 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-12 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-11 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-11-10 | SVB Leerink | Maintains | Outperform |
| 2021-08-16 | SVB Leerink | Maintains | Outperform |
| 2021-05-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-03-02 | Guggenheim | Initiate | Buy |
BOLT BIOTHERAPEUTICS INC / BOLT FAQ
What is the average price target for BOLT BIOTHERAPEUTICS INC (BOLT) stock?
11 analysts have analysed BOLT and the average price target is 27.29 USD. This implies a price increase of 413.84% is expected in the next year compared to the current price of 5.31.
What is the consensus rating for BOLT stock?
The consensus rating for BOLT BIOTHERAPEUTICS INC (BOLT) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BOLT stock?
The number of analysts covering BOLT BIOTHERAPEUTICS INC (BOLT) is 11.